🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Phase 3, international, multicenter, open-label 12 month safety study....
Status
Terminated
Location
Barrow Neurology Clinics, St. Joseph's Hospital and Medical Center, Dignity Health
Start Date
2017-04-10
Trial ID
NCT03051607
Treatments Being Tested
The purpose of this research study is to test the effect of SYN115 compared...
Status
Completed
Location
Multiple Locations
Start Date
2011-03
Trial ID
NCT01283594
The purpose of the study is to investigate how tozadenant is absorbed, dist...
Status
Completed
Location
Pharmaceutical Research Associates Group B.V.
Start Date
2013-09
Trial ID
NCT02240290
Treatments Being Tested
This is a two-part, open label, single-dose study that will evaluate the PK...
Status
Terminated
Location
University of Miami
Start Date
2017-06-30
Trial ID
NCT03212313
Treatments Being Tested
This is an exploratory study to evaluate if SYN115 has an effect on Parkins...
Status
Completed
Location
Washington University St. Louis
Start Date
2008-04
Trial ID
NCT00605553
Treatments Being Tested
The dopamine system is critical in modulation of reward and has been implic...
Status
Completed
Location
University of Texas Health Science Center at Houston
Start Date
2008-10
Trial ID
NCT00783276
This will be a single-dose, randomized, double-blind, active- and placebo-c...
Status
Terminated
Location
INC Research Toronto, Inc.
Start Date
2017-09-18
Trial ID
NCT03200080
Treatments Being Tested
Phase 3, international, multicenter, randomized, double-blind, placebo-cont...
Status
Terminated
Location
Multiple Locations
Start Date
2015-07
Trial ID
NCT02453386
Treatments Being Tested